People who live in rural and remote areas face real struggles to commit to start sight-saving eye injections and to stick with the treatment.
My eyes are our holiday money. I’ve even considered giving up my injections. It’s a
MDFA launches new economic modelling
My Eyes offers a new way to support AMD patients.
Evaluation of MDFA’s education courses for health professionals
A successful project to train practitioners to screen for diabetic eye disease in Indigenous communities across Australia has been extended.
A years-long collaboration between some of Australia’s leading experts in stem cell biology, ophthalmology, and computational biology has produced a genetic roadmap for age-related macular degeneration (AMD) that could be a gamechanger for the discovery of novel treatments.
Vabysmo is a new treatment for age-related macular degeneration and diabetic macular oedema and is now available on the Pharmaceutical Benefits Scheme (PBS) in Australia
MDFA 2022 research update